AR227637A1 - Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles - Google Patents

Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles

Info

Publication number
AR227637A1
AR227637A1 AR279215A AR27921579A AR227637A1 AR 227637 A1 AR227637 A1 AR 227637A1 AR 279215 A AR279215 A AR 279215A AR 27921579 A AR27921579 A AR 27921579A AR 227637 A1 AR227637 A1 AR 227637A1
Authority
AR
Argentina
Prior art keywords
fenoxialquil
imidazoles
derivatives
procedure
preparation
Prior art date
Application number
AR279215A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR227637(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR227637A1 publication Critical patent/AR227637A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR279215A 1978-12-13 1979-12-10 Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles AR227637A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (1)

Publication Number Publication Date
AR227637A1 true AR227637A1 (es) 1982-11-30

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
AR279215A AR227637A1 (es) 1978-12-13 1979-12-10 Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles

Country Status (34)

Country Link
US (2) US4602016A (de)
JP (1) JPS585197B2 (de)
KR (1) KR830001243B1 (de)
AR (1) AR227637A1 (de)
AT (1) AT373879B (de)
AU (1) AU517892B2 (de)
BE (1) BE880584A (de)
CA (1) CA1108137A (de)
CH (1) CH644597A5 (de)
CS (1) CS216517B2 (de)
DD (1) DD147943A5 (de)
DE (1) DE2950019A1 (de)
DK (1) DK471479A (de)
EG (1) EG14227A (de)
ES (1) ES8101556A1 (de)
FI (1) FI70888C (de)
FR (1) FR2444031A1 (de)
GB (1) GB2038821B (de)
GR (1) GR73003B (de)
HU (1) HU183016B (de)
IE (1) IE49318B1 (de)
IL (1) IL58917A (de)
IT (1) IT1194900B (de)
LU (1) LU81985A1 (de)
NL (1) NL177749C (de)
NO (1) NO153135C (de)
NZ (1) NZ192360A (de)
PH (1) PH15056A (de)
PL (1) PL134005B1 (de)
PT (1) PT70571A (de)
SE (1) SE444937B (de)
SU (1) SU878195A3 (de)
YU (1) YU301879A (de)
ZA (1) ZA796708B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−(1−イミダゾリル)アルキルオキシ(またはチオ)ベンゼン誘導体
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES8601148A1 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
US4894385A (en) * 1985-01-16 1990-01-16 Sankyo Company Limited Imidazole derivatives as inhibitors of TXA2 synthesis
SU1739848A3 (ru) 1986-01-28 1992-06-07 Санкио Компани Лимитед (Фирма) Способ получени производных тианафтена или их фармацевтически приемлемых солей
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
AU2890899A (en) * 1998-03-13 1999-09-27 Pozen, Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2003244913A1 (en) * 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
CA2534316A1 (en) * 2003-08-07 2005-02-24 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxygenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
WO2009105140A2 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
SG11201408284VA (en) * 2012-05-22 2015-02-27 Xenon Pharmaceuticals Inc N-substituted benzamides and their use in the treatment of pain
BR112015008987A2 (pt) 2012-10-26 2017-07-04 Merck Sharp & Dohme composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
FI793868A (fi) 1980-06-14
ZA796708B (en) 1981-08-26
NZ192360A (en) 1982-02-23
IT1194900B (it) 1988-09-28
YU301879A (en) 1983-01-21
FR2444031A1 (fr) 1980-07-11
SE444937B (sv) 1986-05-20
NO153135B (no) 1985-10-14
FI70888B (fi) 1986-07-18
DE2950019A1 (de) 1980-07-10
ES486782A0 (es) 1980-12-16
FR2444031B1 (de) 1983-06-10
GB2038821B (en) 1982-12-08
IL58917A0 (en) 1980-03-31
GB2038821A (en) 1980-07-30
PL220351A1 (de) 1980-12-01
PL134005B1 (en) 1985-07-31
JPS585197B2 (ja) 1983-01-29
NL177749B (nl) 1985-06-17
ATA783379A (de) 1983-07-15
CA1108137A (en) 1981-09-01
PT70571A (en) 1980-01-01
US4602016A (en) 1986-07-22
US4636500A (en) 1987-01-13
GR73003B (de) 1984-01-24
KR830001243B1 (ko) 1983-06-27
CS216517B2 (en) 1982-11-26
IE792403L (en) 1980-06-13
AU517892B2 (en) 1981-09-03
NO153135C (no) 1986-01-22
NL7908899A (nl) 1980-06-17
DK471479A (da) 1980-06-14
FI70888C (fi) 1986-10-27
KR830001242A (ko) 1983-04-29
BE880584A (fr) 1980-06-12
NL177749C (nl) 1985-11-18
IT7941669A0 (it) 1979-12-11
SE7910204L (sv) 1980-06-14
CH644597A5 (de) 1984-08-15
IL58917A (en) 1984-03-30
DD147943A5 (de) 1981-04-29
HU183016B (en) 1984-04-28
IE49318B1 (en) 1985-09-18
SU878195A3 (ru) 1981-10-30
NO794069L (no) 1980-06-16
ES8101556A1 (es) 1980-12-16
EG14227A (en) 1983-12-31
LU81985A1 (fr) 1980-04-22
AU5372579A (en) 1980-06-19
JPS5585572A (en) 1980-06-27
AT373879B (de) 1984-02-27
PH15056A (en) 1982-06-03

Similar Documents

Publication Publication Date Title
AR227637A1 (es) Procedimiento para la preparacion de derivados de n-(fenoxialquil)imidazoles
AR222834A1 (es) Procedimiento para la preparacion de derivados de 2-nitroimidazol
MX6387E (es) Procedimiento para la preparacion de n-(heterocicloaminocarbonil)arilsulfonamidas
MX6749E (es) Procedimiento para la preparacion de derivados de tetrazolilalcoxicarboestirilo
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
ES482499A0 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
MX5375E (es) Procedimiento para la preparacion de n-(diaminofosfinil)-arilcarboxamidas
AR221428A1 (es) Procedimiento para la preparacion de derivados de pirrolidinil-y de pirrolidinilmetil-benzamidas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
MX151260A (es) Procedimiento para la preparacion de aminas
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
MX5594E (es) Procedimiento mejorado para la preparacion de derivados de n-trifluoroacetil-n-fosfonometilglicinatos
MX5955E (es) Procedimiento para la preparacion de derivados de piridoxina
ES488835A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
AR223553A1 (es) Procedimiento para la preparacion de n-(4-anilinofenil)metaclilamida
AR223434A1 (es) Procedimiento para la preparacion de derivados de i-piperidino-ftalazina
MX5987E (es) Procedimiento para la preparacion de derivados de la l-cisteina
AR220205A1 (es) Procedimiento de preparacion de nuevos derivados de n-(2-mercaptoetil-carbamoil)-alquil)-fenoxi-alcanoilamidas
MX5445E (es) Procedimiento para la preparacion de derivados de isotiocianobenzotiazol